AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PRINCETON, N.J. -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, announced today that it has provided subscribers with earnings reviews on a number of its Recommended List stocks, including Cerner (NASDAQ:CERN), Philip Morris International(NYSE:PMI), Quest Diagnostics (NYSE:DGX), Aetna (NYSE:AET), and Crown Cork(NYSE:CCK).
All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/index.php?refer=BMR354B
In its report, BullMarket.com wrote: "PMI's across-the-board growth was really quite impressive. Revenues grew 12.6% to $2.44 billion in the European Union; 20.8% to $1.83 billion in Eastern Europe, Middle East, and Africa; 10.2% to $1.55 billion in Asia; and 10.8% to $515 million in Latin America."
BullMarket.com looked at the following topics, among others:
* Why were investors selling Cerner ahead of earnings and why did BullMarket.com think the fears were overblown? How does Cerner's prospects look going forward?
* Should investors get excited over Philip Morris International's ...
Source: HighBeam Research, BullMarket.com Offers Investment Opinion on Cerner, PMI, Quest,...